These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3228591)

  • 1. Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two years.
    Love RR; Mazess RB; Tormey DC; Barden HS; Newcomb PA; Jordan VC
    Breast Cancer Res Treat; 1988 Dec; 12(3):297-302. PubMed ID: 3228591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of effects of tamoxifen and toremifene on bone biochemistry and bone mineral density in postmenopausal breast cancer patients.
    Marttunen MB; Hietanen P; Tiitinen A; Ylikorkala O
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1158-62. PubMed ID: 9543133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in bone mineral density during 5 years of adjuvant treatment in premenopausal breast cancer patients.
    Kim M; Kim H; Ahn SH; Tabatabaie V; Choi SW; Sohn G; Lee SB; Ko BS; Chung IY; Kim J; Lee JW; Son BH; Kim HJ
    Breast Cancer Res Treat; 2020 Apr; 180(3):657-663. PubMed ID: 32072339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.
    Gnant M; Mlineritsch B; Luschin-Ebengreuth G; Kainberger F; Kässmann H; Piswanger-Sölkner JC; Seifert M; Ploner F; Menzel C; Dubsky P; Fitzal F; Bjelic-Radisic V; Steger G; Greil R; Marth C; Kubista E; Samonigg H; Wohlmuth P; Mittlböck M; Jakesz R;
    Lancet Oncol; 2008 Sep; 9(9):840-9. PubMed ID: 18718815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.
    Powles TJ; Hickish T; Kanis JA; Tidy A; Ashley S
    J Clin Oncol; 1996 Jan; 14(1):78-84. PubMed ID: 8558225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years.
    Love RR; Barden HS; Mazess RB; Epstein S; Chappell RJ
    Arch Intern Med; 1994 Nov; 154(22):2585-8. PubMed ID: 7979855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status.
    Vehmanen L; Elomaa I; Blomqvist C; Saarto T
    J Clin Oncol; 2006 Feb; 24(4):675-80. PubMed ID: 16446340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term adjuvant tamoxifen in early breast cancer: effect on bone mineral density in postmenopausal women.
    Fornander T; Rutqvist LE; Sjöberg HE; Blomqvist L; Mattsson A; Glas U
    J Clin Oncol; 1990 Jun; 8(6):1019-24. PubMed ID: 2189951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone mineral density following surgical oophorectomy and tamoxifen adjuvant therapy for breast cancer.
    Love RR; Young GS; Laudico AV; Van Dinh N; Uy GB; Quang le H; De La Peña AS; Dofitas RB; Bisquera OC; Siguan SS; Salvador JD; Mirasol-Lumague MR; Navarro NS; Linh ND; Jarjoura D
    Cancer; 2013 Nov; 119(21):3746-52. PubMed ID: 23963821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in bone turnover and in bone mass in women with breast cancer switched from tamoxifen to exemestane.
    Gonnelli S; Cadirni A; Caffarelli C; Petrioli R; Montagnani A; Franci MB; Lucani B; Francini G; Nuti R
    Bone; 2007 Jan; 40(1):205-10. PubMed ID: 16904960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of exemestane, anastrozole and tamoxifen on bone mineral density and bone turnover markers in postmenopausal early breast cancer patients: results of N-SAS BC 04, the TEAM Japan substudy.
    Aihara T; Suemasu K; Takei H; Hozumi Y; Takehara M; Saito T; Ohsumi S; Masuda N; Ohashi Y
    Oncology; 2010; 79(5-6):376-81. PubMed ID: 21430407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of tamoxifen or exemestane on bone mineral density during the first 2 years of adjuvant treatment of postmenopausal women with early breast cancer.
    Jones S; Stokoe C; Sborov M; Braun M; Ethirajan S; Kutteh L; Pippen J; Patel M; Paul D; Blum JL; Holmes FA; Myron MC; Cantrell J; Hartung NL; Look RM; Di Salle E; Davis JC; Ilegbodu D; Asmar L
    Clin Breast Cancer; 2008 Dec; 8(6):527-32. PubMed ID: 19073509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen and bone metabolism in postmenopausal low-risk breast cancer patients: a randomized study.
    Kristensen B; Ejlertsen B; Dalgaard P; Larsen L; Holmegaard SN; Transbøl I; Mouridsen HT
    J Clin Oncol; 1994 May; 12(5):992-7. PubMed ID: 8164053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study.
    Coleman RE; Banks LM; Girgis SI; Kilburn LS; Vrdoljak E; Fox J; Cawthorn SJ; Patel A; Snowdon CF; Hall E; Bliss JM; Coombes RC;
    Lancet Oncol; 2007 Feb; 8(2):119-27. PubMed ID: 17267326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in bone mineral density during and after 3 years' use of tamoxifen or toremifene.
    Tiitinen A; Nikander E; Hietanen P; Metsä-Heikkilä M; Ylikorkala O
    Maturitas; 2004 Jul; 48(3):321-7. PubMed ID: 15207898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of adjuvant tamoxifen treatment on bone mineral density and bone turnover markers in postmenopausal breast cancer patients in Japan.
    Yoneda K; Tanji Y; Ikeda N; Miyoshi Y; Taguchi T; Tamaki Y; Noguchi S
    Cancer Lett; 2002 Dec; 186(2):223-30. PubMed ID: 12213292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes on bone mineral density after adjuvant treatment in women with non-metastatic breast cancer.
    Rodríguez-Rodríguez LM; Rodríguez-Rodríguez EM; Oramas-Rodríguez JM; Santolaria-Fernandez F; Llanos M; Cruz J; Martínez A; González-Reimers E; Gómez A; Batista N
    Breast Cancer Res Treat; 2005 Sep; 93(1):75-83. PubMed ID: 16184462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer.
    Love RR; Mazess RB; Barden HS; Epstein S; Newcomb PA; Jordan VC; Carbone PP; DeMets DL
    N Engl J Med; 1992 Mar; 326(13):852-6. PubMed ID: 1542321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tamoxifen on bone mineral density and metabolism in postmenopausal women with early-stage breast cancer.
    Zidan J; Keidar Z; Basher W; Israel O
    Med Oncol; 2004; 21(2):117-21. PubMed ID: 15299183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of letrozole versus placebo on bone mineral density in women with primary breast cancer completing 5 or more years of adjuvant tamoxifen: a companion study to NCIC CTG MA.17.
    Perez EA; Josse RG; Pritchard KI; Ingle JN; Martino S; Findlay BP; Shenkier TN; Tozer RG; Palmer MJ; Shepherd LE; Liu S; Tu D; Goss PE
    J Clin Oncol; 2006 Aug; 24(22):3629-35. PubMed ID: 16822845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.